DNA-splicing has proven highly-effective in tests, while fees for procedural and regulatory processes have collectively rendered such treatments not yet logistically viable for the general public.
Technology Reportedly Exists to Eradicate Most Diseases With Gene-Manipulation. The Expense, However, is Prohibitive
Posted in biotech/medical